KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $7.0 billion.

  • Eli Lilly's Operating Expenses rose 2114.99% to $7.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.9 billion, marking a year-over-year increase of 2185.71%. This contributed to the annual value of $24.9 billion for FY2025, which is 2185.76% up from last year.
  • Latest data reveals that Eli Lilly reported Operating Expenses of $7.0 billion as of Q4 2025, which was up 2114.99% from $6.6 billion recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Operating Expenses peaked at $7.0 billion during Q4 2025, and registered a low of $3.2 billion during Q1 2022.
  • In the last 5 years, Eli Lilly's Operating Expenses had a median value of $4.2 billion in 2023 and averaged $4.5 billion.
  • As far as peak fluctuations go, Eli Lilly's Operating Expenses tumbled by 843.14% in 2022, and later soared by 3368.53% in 2025.
  • Eli Lilly's Operating Expenses (Quarter) stood at $3.6 billion in 2021, then rose by 2.29% to $3.7 billion in 2022, then grew by 23.89% to $4.6 billion in 2023, then grew by 27.13% to $5.8 billion in 2024, then increased by 21.15% to $7.0 billion in 2025.
  • Its Operating Expenses was $7.0 billion in Q4 2025, compared to $6.6 billion in Q3 2025 and $6.1 billion in Q2 2025.